- Home
- KAPA vs CCM Comparison
KAPA vs CCM Comparison
Compare KAPA & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAPA
- CCM
- Stock Information
- Founded
- KAPA 2013
- CCM 1997
- Country
- KAPA United States
- CCM China
- Employees
- KAPA N/A
- CCM N/A
- Industry
- KAPA
- CCM Medical/Nursing Services
- Sector
- KAPA
- CCM Health Care
- Exchange
- KAPA NYSE
- CCM Nasdaq
- Market Cap
- KAPA 20.2M
- CCM 20.4M
- IPO Year
- KAPA 2024
- CCM 2009
- Fundamental
- Price
- KAPA $1.60
- CCM $4.66
- Analyst Decision
- KAPA Strong Buy
- CCM
- Analyst Count
- KAPA 1
- CCM 0
- Target Price
- KAPA $9.00
- CCM N/A
- AVG Volume (30 Days)
- KAPA 92.8K
- CCM 4.7K
- Earning Date
- KAPA 11-14-2024
- CCM 01-03-2025
- Dividend Yield
- KAPA N/A
- CCM N/A
- EPS Growth
- KAPA N/A
- CCM N/A
- EPS
- KAPA N/A
- CCM N/A
- Revenue
- KAPA N/A
- CCM $64,910,622.00
- Revenue This Year
- KAPA N/A
- CCM N/A
- Revenue Next Year
- KAPA N/A
- CCM N/A
- P/E Ratio
- KAPA N/A
- CCM N/A
- Revenue Growth
- KAPA N/A
- CCM N/A
- 52 Week Low
- KAPA $1.22
- CCM $3.80
- 52 Week High
- KAPA $4.00
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- KAPA N/A
- CCM 39.29
- Support Level
- KAPA N/A
- CCM $4.24
- Resistance Level
- KAPA N/A
- CCM $4.87
- Average True Range (ATR)
- KAPA 0.00
- CCM 0.36
- MACD
- KAPA 0.00
- CCM 0.02
- Stochastic Oscillator
- KAPA 0.00
- CCM 14.84
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.